Delivery Order SPE2DB20D1100-SPE2DB25FE3K5
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $54,189.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The Defense Logistics Agency awarded a $54,189.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Voranigo 40 mg tablets (30-count units), with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $54,419.24 delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive, competitively awarded transaction executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,094.95 firm fixed-price delivery order contract is for the supply of "VORANIGO 40 MG TABLET 30S", a pharmaceutical product. The contract has an ultimate completion date of July 29, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- The federal contract award is for the delivery of VORANIGO 40 MG TABLET 30S to the Defense Logistics Agency, a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 15, 2025, with a ceiling value of $27,094.95. The contract is a delivery order with a firm fixed price and an ultimate completion date of August 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,581.07 to AmerisourceBergen Drug Corp for Vanflyta 17.7 mg tablets (28-count package) on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,094.95, is for the delivery of VORANIGO 40 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside and was awarded under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999. This IDC serves as a primary...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3K5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count units) valued at $27,094.95 under a firm fixed-price contract type. The contract is non-competitive set-aside and is scheduled for completion by September 19, 2025. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency, supplying a wide range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The underlying IDC enables AmerisourceBergen to fulfill pharmaceutical supply requirements for customers including the Defense Health Agency and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 8/28/25 |